Treatment of mucosal leishmaniasis with amphotericin B lipid complex (ABLC)

Treatment of mucosal leishmaniasis with amphotericin B lipid complex (ABLC)

Bibliographic Details
Main Authors:	Felipe Francisco Tuon, Carolina Rocio Santos, Juliette Cieslinski, Regina Maia de Souza, Rui Imamura, Valdir Sabbaga Amato
Format:	Article
Language:	English
Published:	Universidade de São Paulo 2018-11-01
Series:	Revista do Instituto de Medicina Tropical de São Paulo
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652018005000705&lng=en&tlng=en

Similar Items

Comparative study on liposomal amphotericin B and other therapies in the treatment of mucosal leishmaniasis: A 15-year retrospective cohort study.
by: Carolina Rocio Santos, et al.
Published: (2019-01-01)

Facial structure alterations and abnormalities of the paranasal sinuses on multidetector computed tomography scans of patients with treated mucosal leishmaniasis.
by: Raphael Abegão de Camargo, et al.
Published: (2014-01-01)

Expression of TLR2 and TLR4 in lesions of patients with tegumentary american leishmaniasis
by: Felipe Francisco Tuon, et al.
Published: (2012-06-01)

Neglected tropical diseases: beyond the wars
by: Felipe Francisco Tuon, et al.
Published: (2008-10-01)

USEFULNESS OF kDNA PCR IN THE DIAGNOSIS OF VISCERAL LEISHMANIASIS REACTIVATION IN CO-INFECTED PATIENTS
by: Antonio Carlos Nicodemo, et al.
Published: (2013-12-01)

Paragonimiasis in Brazil
by: Felipe Francisco Tuon, et al.

Mucosal leishmaniasis mimicking T-cell lymphoma in a patient receiving monoclonal antibody against TNFα.
by: Antonio Carlos Nicodemo, et al.
Published: (2017-09-01)

Liposomal amphotericin B and leishmaniasis: Dose and response
by: Shyam Sundar, et al.
Published: (2010-01-01)

Polymer solubilised amphotericin B to treat leishmaniasis
by: Les, Karolina Alicja
Published: (2011)

Modifying amphotericin B for the treatment of cutaneous leishmaniasis
by: Corware, Karina Duarte
Published: (2010)

Intravenous liposomal amphotericin B efficacy and safety for cutaneous and mucosal leishmaniasis: a systematic review and meta-analysis protocol
by: Keren Nathan, et al.
Published: (2021-06-01)

Different liposomal amphotericin B formulations for visceral leishmaniasis
by: Thomas P C Dorlo, et al.
Published: (2014-08-01)

Efficacy of intralesional amphotericin B for the treatment of cutaneous leishmaniasis
by: Vahid Mashayekhi Goyonlo, et al.
Published: (2014-01-01)

Single-dose liposomal amphotericin B for visceral leishmaniasis
by: Nilima A Kshirsagar
Published: (2014-04-01)

Mucosal leishmaniasis
by: Lambertucci José Roberto, et al.
Published: (2003-01-01)

Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B.
by: Gloria Morizot, et al.
Published: (2016-01-01)

An atypical presentation of cutaneous leishmaniasis Uma apresentação atípica de leishmaniose cutânea
by: Valdir Sabbaga Amato, et al.
Published: (2010-08-01)

Daptomycin to bone and joint infections and prosthesis joint infections: a systematic review
by: João Paulo Telles, et al.
Published: (2019-05-01)

Mannosylated nanoparticles for targeted delivery of amphotericin B towards visceral leishmaniasis
by: Daniela Filipa dos Santos Barros
Published: (2019)

Different liposomal amphotericin B formulations for visceral leishmaniasis–Author's reply
by: Nilima Kshirsagar
Published: (2014-08-01)

Single-dose liposomal amphotericin B: an effective treatment for visceral leishmaniasis
by: Prabhat Kumar Sinha, et al.
Published: (2014-01-01)

New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment
by: Miguel Angel Chávez-Fumagalli, et al.
Published: (2015-06-01)

Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis
by: Shabi Parvez, et al.
Published: (2020-07-01)

Cutaneous Leishmaniasis with Mucosal Involvement
by: Mehmet Çabalak, et al.
Published: (2021-09-01)

Voice disorders in mucosal leishmaniasis.
by: Ana Cristina Nunes Ruas, et al.
Published: (2014-01-01)

Transcriptional blood signatures for active and amphotericin B treated visceral leishmaniasis in India.
by: Michaela Fakiola, et al.
Published: (2019-08-01)

"SUCCESSFUL TREATMENT WITH AMPHOTERICIN B OF PATIENTS WITH VISCERAL LEISHMANIASIS RESISTANT TO MEGLUMINE ANTIMONATE"
by: P. Tabatabaie, et al.
Published: (2004-05-01)

"SUCCESSFUL TREATMENT WITH AMPHOTERICIN B OF PATIENTS WITH VISCERAL LEISHMANIASIS RESISTANT TO MEGLUMINE ANTIMONATE"
by: P. Tabatabaie, et al.
Published: (2004-02-01)

Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.
by: Romain Guery, et al.
Published: (2017-11-01)

Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous Leishmaniasis
by: Alaa Riezk, et al.
Published: (2020-09-01)

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
by: Mahmoud Reza Jaafari, et al.
Published: (2019-12-01)

Development of a stable and safe amphotericin B-polymer complex for the treatment of leishmaniasis
by: Mohamed Ahmed, Abeer
Published: (2011)

Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasis.
by: Andrew A Voak, et al.
Published: (2021-03-01)

Utilização do isotionato de pentamidina para o tratamento da leishmaniose mucosa
by: Amato Valdir Sabbaga
Published: (1997-01-01)

Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
by: Célia Faustino, et al.
Published: (2020-01-01)

Chemical stability of amphotericin B in lipid-based media
by: Alencar, Éverton do Nascimento
Published: (2018)

Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate
by: PH Chandrasekar
Published: (2008-12-01)

Mucosal leishmaniasis: epidemiological and clinical aspects
by: Marcus Miranda Lessa, et al.
Published: (2007-11-01)

Enhancement of a TH1 Immune Response in Amphotericin B-Treated Mucocutaneous Leishmaniasis
by: Washington R. Cuna, et al.
Published: (2007-01-01)

Amphotericin B deoxycholate for relapse visceral leishmaniasis in Bangladesh: a cross-sectional study
by: Md Golam Hasnain, et al.
Published: (2018-12-01)